Subscribe to RSS - Option Care

Option Care

Study: Patient monitoring limits adverse drug effects

 - 
03/22/2016

NEW ORLEANS – Close monitoring of patients receiving infusions of infliximab prevented adverse drug events, according to a new study from Option Care.

Outcomes prove value

 - 
01/22/2016

SAN ANTONIO – Although it may seem like a no-brainer that patients who receive infusion therapy at home fare better—and at less cost—than other patients, providers need hard data to make their case to payers, says Paul Mastrapa.

Home infusion costs less, improves outcomes, according to Option Care study

 - 
11/12/2015

SAN ANTONIO – Patients treated with immunoglobulin therapy at home with a high level of clinical oversight by Option Care had better outcomes than others receiving the therapy, according to a recent s

Reporter's notebook: Healthcare reform drives growth

 - 
06/19/2015

Mention the Affordable Care Act to a roomful of HME providers and you’re likely to hear groans about higher costs for their businesses. Home infusion provider Paul Mastrapa, however, sees it as a growth driver.

Option Care has ‘new energy, vision’

By Theresa Flaherty, Managing Editor
 - 
05/22/2015

DEERFIELD, Ill. – Four months after a private equity firm acquired a majority stake in Walgreens Infusion Services, the provider has rebranded as Option Care.

Option Care makes comeback

 - 
05/19/2015

DEERFIELD, Ill. – Walgreens Infusion Services is now Option Care.

Walgreen entered the home infusion market in 2007 when it acquired Option Care for $850 million.

Pride Mobility taps new VP of sales

 - 
04/19/2013

EXETER, Pa. – Pride Mobility Products has named Andrew Pyrih its new senior vice president of domestic sales, according to a press release.

Pages